Covid-19 Impact on Global Molecular Diagnosis and Therapy Market Size, Status and Forecast 2020-2026
Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Molecular Diagnosis and Therapy market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Molecular Diagnosis and Therapy industry.
Based on our recent survey, we have several different scenarios about the Molecular Diagnosis and Therapy YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Molecular Diagnosis and Therapy will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnosis and Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnosis and Therapy market in terms of revenue.
Players, stakeholders, and other participants in the global Molecular Diagnosis and Therapy market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Molecular Diagnosis and Therapy market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Molecular Diagnosis and Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnosis and Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnosis and Therapy market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Molecular Diagnosis and Therapy market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Molecular Diagnosis and Therapy industry.
Based on our recent survey, we have several different scenarios about the Molecular Diagnosis and Therapy YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Molecular Diagnosis and Therapy will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnosis and Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnosis and Therapy market in terms of revenue.
Players, stakeholders, and other participants in the global Molecular Diagnosis and Therapy market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Molecular Diagnosis and Therapy market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Molecular Diagnosis and Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnosis and Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnosis and Therapy market.
The following players are covered in this report:
- Abbott Laboratories
- Agilent Technologies
- Becton, Dickinson and Company
- Biom?rieux Sa
- Danaher Corporation
- Diasorin
- Grifols
- Hologic
- Illumina
- Qiagen
- Roche Diagnostics
- Siemens AG
- Thermo Fisher Scientific
- PCR
- DNA Sequencing
- NGS
- Diagnostic Laboratories
- Research & Academic Laboratories
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Molecular Diagnosis and Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 PCR
1.4.3 DNA Sequencing
1.4.4 NGS
1.5 Market by Application
1.5.1 Global Molecular Diagnosis and Therapy Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Laboratories
1.5.3 Research & Academic Laboratories
1.6 Coronavirus Disease 2019 (Covid-19): Molecular Diagnosis and Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Molecular Diagnosis and Therapy Industry
1.6.1.1 Molecular Diagnosis and Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Molecular Diagnosis and Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Molecular Diagnosis and Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Molecular Diagnosis and Therapy Market Perspective (2015-2026)
2.2 Molecular Diagnosis and Therapy Growth Trends by Regions
2.2.1 Molecular Diagnosis and Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Molecular Diagnosis and Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Molecular Diagnosis and Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Molecular Diagnosis and Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Molecular Diagnosis and Therapy Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Molecular Diagnosis and Therapy Players by Market Size
3.1.1 Global Top Molecular Diagnosis and Therapy Players by Revenue (2015-2020)
3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Molecular Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Molecular Diagnosis and Therapy Market Concentration Ratio
3.2.1 Global Molecular Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis and Therapy Revenue in 2019
3.3 Molecular Diagnosis and Therapy Key Players Head office and Area Served
3.4 Key Players Molecular Diagnosis and Therapy Product Solution and Service
3.5 Date of Enter into Molecular Diagnosis and Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Molecular Diagnosis and Therapy Historic Market Size by Type (2015-2020)
4.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2021-2026)
5 MOLECULAR DIAGNOSIS AND THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
5.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Molecular Diagnosis and Therapy Market Size (2015-2020)
6.2 Molecular Diagnosis and Therapy Key Players in North America (2019-2020)
6.3 North America Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
6.4 North America Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Molecular Diagnosis and Therapy Market Size (2015-2020)
7.2 Molecular Diagnosis and Therapy Key Players in Europe (2019-2020)
7.3 Europe Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
7.4 Europe Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
8 CHINA
8.1 China Molecular Diagnosis and Therapy Market Size (2015-2020)
8.2 Molecular Diagnosis and Therapy Key Players in China (2019-2020)
8.3 China Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
8.4 China Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Molecular Diagnosis and Therapy Market Size (2015-2020)
9.2 Molecular Diagnosis and Therapy Key Players in Japan (2019-2020)
9.3 Japan Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
9.4 Japan Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Molecular Diagnosis and Therapy Market Size (2015-2020)
10.2 Molecular Diagnosis and Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
11 INDIA
11.1 India Molecular Diagnosis and Therapy Market Size (2015-2020)
11.2 Molecular Diagnosis and Therapy Key Players in India (2019-2020)
11.3 India Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
11.4 India Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Molecular Diagnosis and Therapy Market Size (2015-2020)
12.2 Molecular Diagnosis and Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
12.4 Central & South America Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Introduction
13.1.4 Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Agilent Technologies
13.2.1 Agilent Technologies Company Details
13.2.2 Agilent Technologies Business Overview and Its Total Revenue
13.2.3 Agilent Technologies Molecular Diagnosis and Therapy Introduction
13.2.4 Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.2.5 Agilent Technologies Recent Development
13.3 Becton, Dickinson and Company
13.3.1 Becton, Dickinson and Company Company Details
13.3.2 Becton, Dickinson and Company Business Overview and Its Total Revenue
13.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Introduction
13.3.4 Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.3.5 Becton, Dickinson and Company Recent Development
13.4 Biom?rieux Sa
13.4.1 Biom?rieux Sa Company Details
13.4.2 Biom?rieux Sa Business Overview and Its Total Revenue
13.4.3 Biom?rieux Sa Molecular Diagnosis and Therapy Introduction
13.4.4 Biom?rieux Sa Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.4.5 Biom?rieux Sa Recent Development
13.5 Danaher Corporation
13.5.1 Danaher Corporation Company Details
13.5.2 Danaher Corporation Business Overview and Its Total Revenue
13.5.3 Danaher Corporation Molecular Diagnosis and Therapy Introduction
13.5.4 Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.5.5 Danaher Corporation Recent Development
13.6 Diasorin
13.6.1 Diasorin Company Details
13.6.2 Diasorin Business Overview and Its Total Revenue
13.6.3 Diasorin Molecular Diagnosis and Therapy Introduction
13.6.4 Diasorin Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.6.5 Diasorin Recent Development
13.7 Grifols
13.7.1 Grifols Company Details
13.7.2 Grifols Business Overview and Its Total Revenue
13.7.3 Grifols Molecular Diagnosis and Therapy Introduction
13.7.4 Grifols Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.7.5 Grifols Recent Development
13.8 Hologic
13.8.1 Hologic Company Details
13.8.2 Hologic Business Overview and Its Total Revenue
13.8.3 Hologic Molecular Diagnosis and Therapy Introduction
13.8.4 Hologic Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.8.5 Hologic Recent Development
13.9 Illumina
13.9.1 Illumina Company Details
13.9.2 Illumina Business Overview and Its Total Revenue
13.9.3 Illumina Molecular Diagnosis and Therapy Introduction
13.9.4 Illumina Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.9.5 Illumina Recent Development
13.10 Qiagen
13.10.1 Qiagen Company Details
13.10.2 Qiagen Business Overview and Its Total Revenue
13.10.3 Qiagen Molecular Diagnosis and Therapy Introduction
13.10.4 Qiagen Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.10.5 Qiagen Recent Development
13.11 Roche Diagnostics
10.11.1 Roche Diagnostics Company Details
10.11.2 Roche Diagnostics Business Overview and Its Total Revenue
10.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Introduction
10.11.4 Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
10.11.5 Roche Diagnostics Recent Development
13.12 Siemens AG
10.12.1 Siemens AG Company Details
10.12.2 Siemens AG Business Overview and Its Total Revenue
10.12.3 Siemens AG Molecular Diagnosis and Therapy Introduction
10.12.4 Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
10.12.5 Siemens AG Recent Development
13.13 Thermo Fisher Scientific
10.13.1 Thermo Fisher Scientific Company Details
10.13.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
10.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Introduction
10.13.4 Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
10.13.5 Thermo Fisher Scientific Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Molecular Diagnosis and Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 PCR
1.4.3 DNA Sequencing
1.4.4 NGS
1.5 Market by Application
1.5.1 Global Molecular Diagnosis and Therapy Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Laboratories
1.5.3 Research & Academic Laboratories
1.6 Coronavirus Disease 2019 (Covid-19): Molecular Diagnosis and Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Molecular Diagnosis and Therapy Industry
1.6.1.1 Molecular Diagnosis and Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Molecular Diagnosis and Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Molecular Diagnosis and Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Molecular Diagnosis and Therapy Market Perspective (2015-2026)
2.2 Molecular Diagnosis and Therapy Growth Trends by Regions
2.2.1 Molecular Diagnosis and Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Molecular Diagnosis and Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Molecular Diagnosis and Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Molecular Diagnosis and Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Molecular Diagnosis and Therapy Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Molecular Diagnosis and Therapy Players by Market Size
3.1.1 Global Top Molecular Diagnosis and Therapy Players by Revenue (2015-2020)
3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Molecular Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Molecular Diagnosis and Therapy Market Concentration Ratio
3.2.1 Global Molecular Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis and Therapy Revenue in 2019
3.3 Molecular Diagnosis and Therapy Key Players Head office and Area Served
3.4 Key Players Molecular Diagnosis and Therapy Product Solution and Service
3.5 Date of Enter into Molecular Diagnosis and Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Molecular Diagnosis and Therapy Historic Market Size by Type (2015-2020)
4.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2021-2026)
5 MOLECULAR DIAGNOSIS AND THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
5.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Molecular Diagnosis and Therapy Market Size (2015-2020)
6.2 Molecular Diagnosis and Therapy Key Players in North America (2019-2020)
6.3 North America Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
6.4 North America Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Molecular Diagnosis and Therapy Market Size (2015-2020)
7.2 Molecular Diagnosis and Therapy Key Players in Europe (2019-2020)
7.3 Europe Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
7.4 Europe Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
8 CHINA
8.1 China Molecular Diagnosis and Therapy Market Size (2015-2020)
8.2 Molecular Diagnosis and Therapy Key Players in China (2019-2020)
8.3 China Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
8.4 China Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Molecular Diagnosis and Therapy Market Size (2015-2020)
9.2 Molecular Diagnosis and Therapy Key Players in Japan (2019-2020)
9.3 Japan Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
9.4 Japan Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Molecular Diagnosis and Therapy Market Size (2015-2020)
10.2 Molecular Diagnosis and Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
11 INDIA
11.1 India Molecular Diagnosis and Therapy Market Size (2015-2020)
11.2 Molecular Diagnosis and Therapy Key Players in India (2019-2020)
11.3 India Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
11.4 India Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Molecular Diagnosis and Therapy Market Size (2015-2020)
12.2 Molecular Diagnosis and Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Molecular Diagnosis and Therapy Market Size by Type (2015-2020)
12.4 Central & South America Molecular Diagnosis and Therapy Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Introduction
13.1.4 Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Agilent Technologies
13.2.1 Agilent Technologies Company Details
13.2.2 Agilent Technologies Business Overview and Its Total Revenue
13.2.3 Agilent Technologies Molecular Diagnosis and Therapy Introduction
13.2.4 Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.2.5 Agilent Technologies Recent Development
13.3 Becton, Dickinson and Company
13.3.1 Becton, Dickinson and Company Company Details
13.3.2 Becton, Dickinson and Company Business Overview and Its Total Revenue
13.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Introduction
13.3.4 Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.3.5 Becton, Dickinson and Company Recent Development
13.4 Biom?rieux Sa
13.4.1 Biom?rieux Sa Company Details
13.4.2 Biom?rieux Sa Business Overview and Its Total Revenue
13.4.3 Biom?rieux Sa Molecular Diagnosis and Therapy Introduction
13.4.4 Biom?rieux Sa Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.4.5 Biom?rieux Sa Recent Development
13.5 Danaher Corporation
13.5.1 Danaher Corporation Company Details
13.5.2 Danaher Corporation Business Overview and Its Total Revenue
13.5.3 Danaher Corporation Molecular Diagnosis and Therapy Introduction
13.5.4 Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.5.5 Danaher Corporation Recent Development
13.6 Diasorin
13.6.1 Diasorin Company Details
13.6.2 Diasorin Business Overview and Its Total Revenue
13.6.3 Diasorin Molecular Diagnosis and Therapy Introduction
13.6.4 Diasorin Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.6.5 Diasorin Recent Development
13.7 Grifols
13.7.1 Grifols Company Details
13.7.2 Grifols Business Overview and Its Total Revenue
13.7.3 Grifols Molecular Diagnosis and Therapy Introduction
13.7.4 Grifols Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.7.5 Grifols Recent Development
13.8 Hologic
13.8.1 Hologic Company Details
13.8.2 Hologic Business Overview and Its Total Revenue
13.8.3 Hologic Molecular Diagnosis and Therapy Introduction
13.8.4 Hologic Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.8.5 Hologic Recent Development
13.9 Illumina
13.9.1 Illumina Company Details
13.9.2 Illumina Business Overview and Its Total Revenue
13.9.3 Illumina Molecular Diagnosis and Therapy Introduction
13.9.4 Illumina Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.9.5 Illumina Recent Development
13.10 Qiagen
13.10.1 Qiagen Company Details
13.10.2 Qiagen Business Overview and Its Total Revenue
13.10.3 Qiagen Molecular Diagnosis and Therapy Introduction
13.10.4 Qiagen Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
13.10.5 Qiagen Recent Development
13.11 Roche Diagnostics
10.11.1 Roche Diagnostics Company Details
10.11.2 Roche Diagnostics Business Overview and Its Total Revenue
10.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Introduction
10.11.4 Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
10.11.5 Roche Diagnostics Recent Development
13.12 Siemens AG
10.12.1 Siemens AG Company Details
10.12.2 Siemens AG Business Overview and Its Total Revenue
10.12.3 Siemens AG Molecular Diagnosis and Therapy Introduction
10.12.4 Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
10.12.5 Siemens AG Recent Development
13.13 Thermo Fisher Scientific
10.13.1 Thermo Fisher Scientific Company Details
10.13.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
10.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Introduction
10.13.4 Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2015-2020)
10.13.5 Thermo Fisher Scientific Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Molecular Diagnosis and Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Molecular Diagnosis and Therapy Revenue
Table 3. Ranking of Global Top Molecular Diagnosis and Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of PCR
Table 6. Key Players of DNA Sequencing
Table 7. Key Players of NGS
Table 8. COVID-19 Impact Global Market: (Four Molecular Diagnosis and Therapy Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Molecular Diagnosis and Therapy Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Molecular Diagnosis and Therapy Players to Combat Covid-19 Impact
Table 13. Global Molecular Diagnosis and Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Molecular Diagnosis and Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Molecular Diagnosis and Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Molecular Diagnosis and Therapy Market Share by Regions (2015-2020)
Table 17. Global Molecular Diagnosis and Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Molecular Diagnosis and Therapy Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Molecular Diagnosis and Therapy Market Growth Strategy
Table 23. Main Points Interviewed from Key Molecular Diagnosis and Therapy Players
Table 24. Global Molecular Diagnosis and Therapy Revenue by Players (2015-2020) (Million US$)
Table 25. Global Molecular Diagnosis and Therapy Market Share by Players (2015-2020)
Table 26. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis and Therapy as of 2019)
Table 27. Global Molecular Diagnosis and Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Molecular Diagnosis and Therapy Product Solution and Service
Table 30. Date of Enter into Molecular Diagnosis and Therapy Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 33. Global Molecular Diagnosis and Therapy Market Size Share by Type (2015-2020)
Table 34. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2021-2026)
Table 35. Global Molecular Diagnosis and Therapy Market Size Share by Application (2015-2020)
Table 36. Global Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. Global Molecular Diagnosis and Therapy Market Size Share by Application (2021-2026)
Table 38. North America Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 40. North America Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. North America Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 42. North America Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. North America Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 44. Europe Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 46. Europe Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 48. Europe Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 50. China Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 51. China Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 52. China Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. China Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 54. China Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. China Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 56. Japan Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 58. Japan Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 60. Japan Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 64. Southeast Asia Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 66. Southeast Asia Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 68. India Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 69. India Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 70. India Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. India Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 72. India Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. India Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 76. Central & South America Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 78. Central & South America Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 80. Abbott Laboratories Company Details
Table 81. Abbott Laboratories Business Overview
Table 82. Abbott Laboratories Product
Table 83. Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 84. Abbott Laboratories Recent Development
Table 85. Agilent Technologies Company Details
Table 86. Agilent Technologies Business Overview
Table 87. Agilent Technologies Product
Table 88. Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 89. Agilent Technologies Recent Development
Table 90. Becton, Dickinson and Company Company Details
Table 91. Becton, Dickinson and Company Business Overview
Table 92. Becton, Dickinson and Company Product
Table 93. Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 94. Becton, Dickinson and Company Recent Development
Table 95. Biom?rieux Sa Company Details
Table 96. Biom?rieux Sa Business Overview
Table 97. Biom?rieux Sa Product
Table 98. Biom?rieux Sa Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 99. Biom?rieux Sa Recent Development
Table 100. Danaher Corporation Company Details
Table 101. Danaher Corporation Business Overview
Table 102. Danaher Corporation Product
Table 103. Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 104. Danaher Corporation Recent Development
Table 105. Diasorin Company Details
Table 106. Diasorin Business Overview
Table 107. Diasorin Product
Table 108. Diasorin Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 109. Diasorin Recent Development
Table 110. Grifols Company Details
Table 111. Grifols Business Overview
Table 112. Grifols Product
Table 113. Grifols Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 114. Grifols Recent Development
Table 115. Hologic Business Overview
Table 116. Hologic Product
Table 117. Hologic Company Details
Table 118. Hologic Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 119. Hologic Recent Development
Table 120. Illumina Company Details
Table 121. Illumina Business Overview
Table 122. Illumina Product
Table 123. Illumina Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 124. Illumina Recent Development
Table 125. Qiagen Company Details
Table 126. Qiagen Business Overview
Table 127. Qiagen Product
Table 128. Qiagen Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 129. Qiagen Recent Development
Table 130. Roche Diagnostics Company Details
Table 131. Roche Diagnostics Business Overview
Table 132. Roche Diagnostics Product
Table 133. Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 134. Roche Diagnostics Recent Development
Table 135. Siemens AG Company Details
Table 136. Siemens AG Business Overview
Table 137. Siemens AG Product
Table 138. Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 139. Siemens AG Recent Development
Table 140. Thermo Fisher Scientific Company Details
Table 141. Thermo Fisher Scientific Business Overview
Table 142. Thermo Fisher Scientific Product
Table 143. Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 144. Thermo Fisher Scientific Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 1. Molecular Diagnosis and Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Molecular Diagnosis and Therapy Revenue
Table 3. Ranking of Global Top Molecular Diagnosis and Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of PCR
Table 6. Key Players of DNA Sequencing
Table 7. Key Players of NGS
Table 8. COVID-19 Impact Global Market: (Four Molecular Diagnosis and Therapy Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Molecular Diagnosis and Therapy Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Molecular Diagnosis and Therapy Players to Combat Covid-19 Impact
Table 13. Global Molecular Diagnosis and Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Molecular Diagnosis and Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Molecular Diagnosis and Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Molecular Diagnosis and Therapy Market Share by Regions (2015-2020)
Table 17. Global Molecular Diagnosis and Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Molecular Diagnosis and Therapy Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Molecular Diagnosis and Therapy Market Growth Strategy
Table 23. Main Points Interviewed from Key Molecular Diagnosis and Therapy Players
Table 24. Global Molecular Diagnosis and Therapy Revenue by Players (2015-2020) (Million US$)
Table 25. Global Molecular Diagnosis and Therapy Market Share by Players (2015-2020)
Table 26. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis and Therapy as of 2019)
Table 27. Global Molecular Diagnosis and Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Molecular Diagnosis and Therapy Product Solution and Service
Table 30. Date of Enter into Molecular Diagnosis and Therapy Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 33. Global Molecular Diagnosis and Therapy Market Size Share by Type (2015-2020)
Table 34. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2021-2026)
Table 35. Global Molecular Diagnosis and Therapy Market Size Share by Application (2015-2020)
Table 36. Global Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. Global Molecular Diagnosis and Therapy Market Size Share by Application (2021-2026)
Table 38. North America Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 40. North America Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. North America Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 42. North America Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. North America Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 44. Europe Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 46. Europe Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 48. Europe Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 50. China Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 51. China Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 52. China Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. China Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 54. China Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. China Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 56. Japan Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 58. Japan Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 60. Japan Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 64. Southeast Asia Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 66. Southeast Asia Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 68. India Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 69. India Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 70. India Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. India Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 72. India Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. India Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Molecular Diagnosis and Therapy Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Molecular Diagnosis and Therapy Market Share (2019-2020)
Table 76. Central & South America Molecular Diagnosis and Therapy Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Molecular Diagnosis and Therapy Market Share by Type (2015-2020)
Table 78. Central & South America Molecular Diagnosis and Therapy Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Molecular Diagnosis and Therapy Market Share by Application (2015-2020)
Table 80. Abbott Laboratories Company Details
Table 81. Abbott Laboratories Business Overview
Table 82. Abbott Laboratories Product
Table 83. Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 84. Abbott Laboratories Recent Development
Table 85. Agilent Technologies Company Details
Table 86. Agilent Technologies Business Overview
Table 87. Agilent Technologies Product
Table 88. Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 89. Agilent Technologies Recent Development
Table 90. Becton, Dickinson and Company Company Details
Table 91. Becton, Dickinson and Company Business Overview
Table 92. Becton, Dickinson and Company Product
Table 93. Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 94. Becton, Dickinson and Company Recent Development
Table 95. Biom?rieux Sa Company Details
Table 96. Biom?rieux Sa Business Overview
Table 97. Biom?rieux Sa Product
Table 98. Biom?rieux Sa Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 99. Biom?rieux Sa Recent Development
Table 100. Danaher Corporation Company Details
Table 101. Danaher Corporation Business Overview
Table 102. Danaher Corporation Product
Table 103. Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 104. Danaher Corporation Recent Development
Table 105. Diasorin Company Details
Table 106. Diasorin Business Overview
Table 107. Diasorin Product
Table 108. Diasorin Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 109. Diasorin Recent Development
Table 110. Grifols Company Details
Table 111. Grifols Business Overview
Table 112. Grifols Product
Table 113. Grifols Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 114. Grifols Recent Development
Table 115. Hologic Business Overview
Table 116. Hologic Product
Table 117. Hologic Company Details
Table 118. Hologic Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 119. Hologic Recent Development
Table 120. Illumina Company Details
Table 121. Illumina Business Overview
Table 122. Illumina Product
Table 123. Illumina Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 124. Illumina Recent Development
Table 125. Qiagen Company Details
Table 126. Qiagen Business Overview
Table 127. Qiagen Product
Table 128. Qiagen Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 129. Qiagen Recent Development
Table 130. Roche Diagnostics Company Details
Table 131. Roche Diagnostics Business Overview
Table 132. Roche Diagnostics Product
Table 133. Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 134. Roche Diagnostics Recent Development
Table 135. Siemens AG Company Details
Table 136. Siemens AG Business Overview
Table 137. Siemens AG Product
Table 138. Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 139. Siemens AG Recent Development
Table 140. Thermo Fisher Scientific Company Details
Table 141. Thermo Fisher Scientific Business Overview
Table 142. Thermo Fisher Scientific Product
Table 143. Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2015-2020) (Million US$)
Table 144. Thermo Fisher Scientific Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Molecular Diagnosis and Therapy Market Share by Type: 2020 VS 2026
Figure 2. PCR Features
Figure 3. DNA Sequencing Features
Figure 4. NGS Features
Figure 5. Global Molecular Diagnosis and Therapy Market Share by Application: 2020 VS 2026
Figure 6. Diagnostic Laboratories Case Studies
Figure 7. Research & Academic Laboratories Case Studies
Figure 8. Molecular Diagnosis and Therapy Report Years Considered
Figure 9. Global Molecular Diagnosis and Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Molecular Diagnosis and Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Molecular Diagnosis and Therapy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Molecular Diagnosis and Therapy Market Share by Players in 2019
Figure 14. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis and Therapy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Molecular Diagnosis and Therapy Revenue in 2019
Figure 16. North America Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abbott Laboratories Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 25. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Agilent Technologies Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 27. Becton, Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Becton, Dickinson and Company Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 29. Biom?rieux Sa Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Biom?rieux Sa Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 31. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Danaher Corporation Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 33. Diasorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Diasorin Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 35. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Grifols Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 37. Hologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Hologic Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 39. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Illumina Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 41. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Qiagen Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 43. Roche Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Roche Diagnostics Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 45. Siemens AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Siemens AG Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 47. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Figure 1. Global Molecular Diagnosis and Therapy Market Share by Type: 2020 VS 2026
Figure 2. PCR Features
Figure 3. DNA Sequencing Features
Figure 4. NGS Features
Figure 5. Global Molecular Diagnosis and Therapy Market Share by Application: 2020 VS 2026
Figure 6. Diagnostic Laboratories Case Studies
Figure 7. Research & Academic Laboratories Case Studies
Figure 8. Molecular Diagnosis and Therapy Report Years Considered
Figure 9. Global Molecular Diagnosis and Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Molecular Diagnosis and Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Molecular Diagnosis and Therapy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Molecular Diagnosis and Therapy Market Share by Players in 2019
Figure 14. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis and Therapy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Molecular Diagnosis and Therapy Revenue in 2019
Figure 16. North America Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Molecular Diagnosis and Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abbott Laboratories Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 25. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Agilent Technologies Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 27. Becton, Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Becton, Dickinson and Company Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 29. Biom?rieux Sa Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Biom?rieux Sa Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 31. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Danaher Corporation Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 33. Diasorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Diasorin Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 35. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Grifols Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 37. Hologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Hologic Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 39. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Illumina Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 41. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Qiagen Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 43. Roche Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Roche Diagnostics Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 45. Siemens AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Siemens AG Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 47. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
